Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01514422 · ClinicalTrials.gov registry record · Phase 4

Minocycline for Bipolar Depression

A Phase 4 study of Bipolar Depression, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
Phase 4
Development phase
20
Enrollment target
1
Study location

NCT01514422 is a Phase 4 study of Bipolar Depression that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 20 participants, below the 215-participant average among 29 other Bipolar Depression trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01514422, a Phase 4 study of Bipolar Depression, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
Phase 4
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate minocycline as a potential treatment for bipolar depression when added to a mood-stabilizing medication. Minocycline is an antibiotic that is approved for the treatment of infections and acne. Participation in this research study is expected to last 8 weeks, and includes five outpatient visits.

Conditions Studied

Bipolar Depression

Interventions

  • DRUG Minocycline

Study Locations (1)

New York

  • Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2011-05
Est. Completion 2013-08
Phase Phase 4

Sponsor

Icahn School of Medicine at Mount Sinai

708 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01514422

The ClinicalTrials.gov registry entry for NCT01514422 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 215-participant average among 29 other Bipolar Depression trials with a reported enrollment target (91% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Bipolar Depression appearing as the primary indexed condition, and to 1 intervention - of which Minocycline is the first listed.

NCT01514422 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01514422 about?

NCT01514422 is a clinical study titled "Minocycline for Bipolar Depression". The purpose of this study is to evaluate minocycline as a potential treatment for bipolar depression when added to a mood-stabilizing medication. Minocycline is an antibiotic that is approved for the treatment of infections and acne. Participation in this research study is expected to last 8 weeks, ...

What is the current status of trial NCT01514422?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2011-05. Estimated completion is 2013-08.

What conditions does trial NCT01514422 study?

This clinical trial studies the following conditions: Bipolar Depression.

What interventions are being tested in trial NCT01514422?

The interventions under investigation include: Minocycline (DRUG).

Who is sponsoring clinical trial NCT01514422?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01514422 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Bipolar Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Bipolar Depression

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.